Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

NCT05476939 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT05476939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05476939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Phase 3
Overall status
Recruiting
Start date
September 29, 2022
Completion date
September 30, 2031
Enrollment
433 (estimated)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse intrinsic pontine glioma, diffuse midline glioma, h3 k27m-mutant, diffuse midline glioma, h3k27-altered